Approval · Notice of Compliance 5703 · 1994
HYDRALAZINE: Notice of Compliance 5703
Issued March 10, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5703
- Date
- March 10, 1994
- Company
- Laboratoires Pro Doc Limitée
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New strengths
- Therapeutic class
- Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDRALAZINE | 02082071 | Cancelled Post Market |
| HYDRALAZINE | 02082098 | Cancelled Post Market |
Medicinal ingredients
- HYDRALAZINE HCL 25 MG per TAB
- HYDRALAZINE HCL 50 MG per TAB